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DopamineLatent inhibition (LI) manifests as poorer conditioning to a CS that has previously been presented without
consequence. There is some evidence that LI can be potentiated by reduced mesoaccumbal dopamine (DA)
function but the locus within the nucleus accumbens of this effect is as yet not ﬁrmly established. Experiment
1 tested whether 6-hydroxydopamine (6-OHDA)-induced lesions of DA terminals within the core and medial
shell subregions of the nucleus accumbens (NAc) would enhance LI under conditions that normally disrupt LI
in controls (weak pre-exposure). LI was measured in a thirst motivated conditioned emotional response
procedure with 10 pre-exposures (to a noise CS) and 2 conditioning trials. The vehicle-injected and core-
lesioned animals did not show LI and conditioned to the pre-exposed CS at comparable levels to the
non-pre-exposed controls. 6-OHDA lesions to the medial shell, however, produced potentiation of LI,
demonstrated across two extinction tests. In a subsequent experiment, haloperidol microinjected into the
medial shell prior to conditioning similarly enhanced LI. These results underscore the dissociable roles of core
and shell subregions of the NAc inmediating the expression of LI and indicate that reduced DA functionwithin
the medial shell leads to enhanced LI.sity of Nottingham, University
115 951 5124; fax: +44 115
.J. Cassaday).
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Latent inhibition (LI) refers to the process whereby non-reinforced
pre-exposure to a stimulus normally reduces the level of associative
learning that the pre-exposed stimulus can support (Lubow and
Moore, 1959). LI is disrupted by amphetamine in both rats (Solomon
et al., 1981; Weiner et al., 1984) and humans (Gray et al., 1992;
Kumari et al., 1999) and is absent in acutely ill schizophrenia patients
(Baruch et al., 1988). Conversely, LI is potentiated by antipsychotics in
both rats (Weiner and Feldon, 1987; Shadach et al., 2000) and humans
(Williams et al., 1997). Consequently, LI has received considerable
attention as a putative animal model of cognitive deﬁcits in schizophre-
nia (e.g., Weiner, 1990, 2003; Gray et al., 1991;Weiner and Arad, 2009).
Investigations into the neural substrates of LI have shown that the
nucleus accumbens (NAc) and its afferent connections from the
entorhinal cortex, hippocampus and basalateral amygdala play a key
role in the regulation of LI (for review see Weiner, 2003). The
demonstration that LI is acutely sensitive to manipulations of
forebrain dopamine (DA) has led to a particular focus on the
contribution of the NAc and its dopaminergic innervation tomediating the expression of LI. For example, infusions of amphet-
amine into the NAc have been shown under some circumstances to
abolish LI (Solomon and Staton, 1982; Joseph et al., 2000; cf. Killcross
and Robbins, 1983; Ellenbroek et al., 1997; Nelson et al., in press) and
the disruptive effects of systemic amphetamine on LI can be blocked
by intra-accumbal infusions of the DA antagonist haloperidol (Joseph
et al., 2000). Similarly, 6-OHDA-induced DA depletion of the NAc leads
to the emergence of LI under conditions that do not produce LI in
control animals (Joseph et al., 2000).
However, it is now indisputably established that the NAc is a
heterogeneous structure with at least two morphologically and neu-
rochemically distinct subregions, shell and core (Zahm and Brog,
1992), that have also been functionally dissociated (e.g., Parkinson
et al., 1999; Di Chiara, 2002; Sellings and Clarke, 2003; Floresco et al.,
2006). Consistent with these reports, there is very good evidence that
the core and shell subterritories of the NAc are differentially involved
in LI. Excitotoxic and electrolytic lesions to the shell disrupt LI but the
effect is spared by similar lesions to core NAc (Tai et al., 1995; Weiner
et al., 1996; Gal et al., 2005; Pothuizen et al., 2005). These ﬁndings
have led to the suggestion that the core mediates responding to CS-
reinforcement contingencies at conditioning and the shell inhibits
this core-based switching mechanism (Weiner, 1990, 2003; Gal et al.,
2005; Weiner and Arad, 2009).
To date, the effects of intra-accumbal manipulations of DA to
differentiate the role of the core and shell subregions on LI have not
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in NAc sub-regions in LI have used experimental parameters designed
to produce reliable LI in the vehicle controls (Nelson et al., in press)—
because these are the parameters suitable to test for disruption —
but few studies have examined the role of NAc subregions under
experimental conditions that do not yield LI in controls (Joseph et al.,
2000). Experiment 1 tested the effects of 6-OHDA lesions targeted at
the core and medial shell on LI using experimental parameters
speciﬁcally designed to prevent the emergence of LI in normal rats
(weak pre-exposure). This was followed in Experiment 2, by an
examination of the effect of haloperidol microinjected prior to
conditioning into the core or medial shell using the same behavioral
parameters as Experiment 1.
2. Materials and methods
2.1. Subjects
In each experiment, the subjects were 72 adult male Wistar rats
(Charles River, UK), caged in pairs on a 12:12 h light/dark cycle with
food and water ad libitum. Rats were handled for approximately
10 min per day for 1 week and then atmeanweight 234 g (range 198–
270 g) underwent surgery. In Experiment 1, 24 rats were randomly
allocated to each of the core and shell lesion group and a total of 24
rats were allocated to the lesion control group (12 rats were vehicle-
injected at the core coordinates and 12 rats were vehicle-injected at
the shell coordinates). In Experiment 2, 34 animals were successfully
implanted with guide cannulae aimed at the core and 34 with guide
cannulae aimed at the shell.
All procedures were carried out in accordance with the United
Kingdom (UK) Animals Scientiﬁc Procedures Act 1986, Project Licence
number: PPL 40/3163. The UK Act ensures full compliance with the
“Principles of laboratory animal care” (NIH publication no. 86-23, revised
1985) and the EC Directive 86/609/EEC for animal experiments.
2.2. Behavioral apparatus
Six identical fully automated conditioning chambers, housed with-
in sound-attenuating cases containing ventilation fans (Cambridge
Cognition, Cambridge, UK), were used. Each of the inner conditioning
chambers consisted of a plain steel box (25 cm×25 cm×22 cm high)
with a Plexiglas door (27 cm×21 cmhigh) at the front. The ﬂoorwas a
shock grid with steel bars 1 cm apart and 1 cm above the lip of a 7 cm
deep sawdust tray. A waterspout wasmounted on one wall. The spout
was 5 cm above the ﬂoor and connected to a lickometer supplied by
a pump. Licks were registered by a break in the photo beam within
the spout, which also triggered water delivery of 0.05 ml per lick. The
waterspout was illuminated whenwater was available. A loudspeaker
was set in the roof and delivered a 5 s mixed frequency noise set at
85 dB (including background) as the conditioned stimulus (CS).
Footshock of 1 s duration and 1 mA intensity provided the uncondi-
tioned stimulus (UCS). This was delivered through the grid ﬂoor by
a constant current shock generator (pulsed voltage: output square
wave 10 ms on, 80 ms off, 370 V peak under no load conditions,
MISAC Systems, Newbury, UK). Stimulus control and data collection
was by an Acorn Archimedes RISC computer programmed in Basic
with additional interfacing using an Arachnid extension (Cambridge
Cognition).
2.3. Behavioral procedure
Water deprivation was introduced 1 day prior to shaping. There-
after, the animals received 1 h and 15 min of ad libitum access to
water in their home cage in addition to water in the experimental
chambers.2.3.1. Pre-conditioning
Rats were shaped for 1 day until all drank from thewaterspout and
were then individually assigned to a conditioning box. They then
drank in the allocated box for 15 min (timed from ﬁrst lick) on each of
5 days. The drinking spout was illuminated throughout, but no other
stimuli were presented. Latency to ﬁrst lick was measured as an
indicator of habituation to the experimental context. Total number of
licks was also recorded each day to assess any pre-existing differences
in drinking (prior to conditioning).
2.3.2. Pre-exposure
The pre-exposed (PE) animals received 10 5 s CS presentations
with an average inter-stimulus-interval of 60 s. The non-pre-exposed
(NPE) control animals were conﬁned to the boxes for an identical
period of time (10 min)without receiving the CS presentations.Water
was not available and the waterspout was not illuminated during the
pre-exposure session.
2.3.3. Conditioning
Conditioning was conducted on the following day. No water
was available and the waterspout was not illuminated. There were
2 conditioning trials in which the UCS footshock was delivered
following termination of the CS. The ﬁrst pairing of CS and UCS was
presented after 5 min had elapsed, and the second pairing was 5 min
after the ﬁrst, followed by a further 5 min left in the apparatus. In the
absence of drinking, there were no behavioral measures to record.
2.3.4. Reshaping
24 h after conditioning, animals were reshaped following the
same procedure as in pre-conditioning sessions. This was in order to
re-establish drinking after conditioning. Reshaping also provided
measures of conditioning to the box context (latency to ﬁrst lick).
2.3.5. Extinction tests
On the day following reshaping, water was available throughout
the test and the waterspout was illuminated. The program was
triggered by each rat's ﬁrst lick. Then once the rat had made 50 licks,
the CS was presented for 15 min. Excluding the time to ﬁrst lick, the
latency to make 50 licks in the absence of the CS (the A period)
provided a measure of any individual variation in baseline lick
responding. This was compared with the time taken to complete 50
licks following CS onset (B period) in a suppression ratio (A/(A+B))
to assess the level of conditioning to the CS, adjusted for any
individual variation in drink rate. On the next day, animals underwent
an identical extinction test (Experiment 1 only).
2.4. Experiment 1
2.4.1. Surgery
This took place prior to any behavioral procedures. All rats were
pre-treatedwith desipramine (20 mg/kg, s.c.) 40 min prior to surgery.
Anaesthesia was induced by isoﬂurane (4%) in a N2O/O2 (1:2, v/v)
mixture and maintained with isoﬂurane (1–2%). Stereotaxic surgery
was conducted with the incisor bar set at −3.3 mm below the intra-
aural line. A craniotomy was performed with a 1 mm hand drill and
the dura was cut to expose the cortex. Rats received bilateral infusions
of 6-OHDA or vehicle into either NAc core or medial shell at
the following stereotaxic coordinates from bregma — core:
AP +1.6 mm, ML ±1.8 mm, DV−6.8 mm; medial shell: AP +1.3 mm,
ML ±0.8 mm, DV −6.4 mm and 7.0 mm (Paxinos and Watson, 2005).
DV coordinateswere taken fromdura (1 infusion at eachDV coordinate).
Infusions were made via a 31 gauge stainless steel injector attached by
polythene tubing to a 1 μl Hamilton syringe. 6-OHDA hydrobromide
(24 mg/ml as salt dissolved in vehicle; Sigma, UK) or vehicle (0.9% saline/
ascorbic acid 0.01% w/v) was infused manually over 2 min on each side
in a volume of 0.5 μl (core) or as 2 infusions of 0.25 μl (medial shell).
Fig. 1. Mean suppression ratio (±S.E.M.) to the CS for non-pre-exposed (NPE: white
bars) and pre-exposed (PE: light grey) groups following vehicle or 6-OHDA lesions to
either the core or shell subregions of the nucleus accumbens.
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and to minimize spread of the toxin.
Rimadyl (0.03 ml s.c.) provided post-operative analgesia. Animals
were allowed 5 days recovery before the commencement of behav-
ioral testing.
2.4.2. Neurotransmitter assay
Following the completion of behavioral testing, the animals were
humanely killed by dislocation of the neck and then decapitated. The
brains were removed and dissected on a cold tray using a brain matrix
(Harvard Instruments, USA). The brain samples were then frozen on
dry ice and stored at−80 °C. A stainless steel micropunch was used to
remove samples of tissue from the following (left and right) brain
regions: core NAc, medial shell NAc, dorsolateral striatum (DLS),
prelimbic (PL) cortex and infralimbic (IL) cortex. The tissue samples
were homogenised in 0.1 M PCA solution and centrifuged. Neuro-
transmitter levels in the samples were determined by high-pressure
liquid chromatography (HPLC) with electrochemical detection.
Bradford assay was used to adjust for protein content.
2.5. Experiment 2
2.5.1. Surgery
Animals underwent the same surgical procedure as in Experiment
1, except that bilateral stainless steel guide cannulae (22 gauge, length
11 mm below guide; Plastic One, Roanoke, VA, USA) were implanted
to allow subsequent micro-injection (see 2.5.2). Guide cannulae
were aimed at the NAc core or medial shell at the following stereo-
taxic coordinates from bregma — core: AP +1.6 mm, ML ±1.9 mm,
DV−4.8 mm;medial shell: AP+1.3 mm,ML±0.75 mm,DV−4.7 mm.
Cannulae were held in place by dental cement and anchored to the skull
with four ﬁxing screws located on different bone plates. Removable
obturatorswere inserted into the guide cannulae to prevent the cannulae
from blocking.
As in Experiment 1, Rimadyl (0.03 ml s.c.) provided post-operative
analgesia. Animals were allowed 5 days recovery before the com-
mencement of behavioral testing.
2.5.2. Haloperidol microinjection
Haloperidol (Antigen Pharmaceuticals, Croydon, UK) was dis-
solved in saline and the pH was adjusted to ~6.5 with NaOH. It
was injected at a dose of 0.5 μg/0.5 μl per hemisphere prior to the
conditioning stage of Experiment 2 (Joseph et al., 2000). Rats were
lightly restrained, the dust caps and obturators were removed, and 31
gauge stainless steel infusion cannulae that protruded 2 mm beyond
the tip of the guide cannulae were inserted into either the core or shell
of the NAc. The infusion cannulae were connected to two 5 μl syringes
mounted on an infusion pump. Haloperidol was injected over 1 min
and the infusion cannulae were left in situ for a further 1 min to allow
absorption of the bolus. The infusion cannulae were then removed
and the obturators and dust caps replaced. The animals were returned
to the home cage before the onset of conditioning which took place
10 min after completion of themicroinjection. Control animals under-
went the identical procedure but received infusions of saline. In total,
22 animals received microinjections of haloperidol into the core and
24 into the shell; 11 animals were infused with saline into the core
and 11 into the shell (see 3.2.1 for ﬁnal cell sizes).
2.5.3. Histological assessment of cannulae placement
Following the completion of behavioral testing, rats received a
lethal dose of sodium pentobarbitone. To aid veriﬁcation of the place-
ment of the cannulae tips, infusion cannulae were inserted and 0.5 μl
Pontamine sky blue dye was infused following the microinfusion
procedure described above. Then the animals were immediately
decapitated with a guillotine. The headcaps and guide cannulae were
removed and the brain taken out and ﬁxed in 4% formal saline for atleast 7 days. Slices (80 μm thick) were made using a vibratome and
were mounted onto gelatine-coated slides. Placement of the infusion
cannulae tips was veriﬁed with a light microscope and the atlas of
Paxinos and Watson (2005).
2.6. Design and analysis
Initial analyses of the behavioral results revealed unexpected
effects of the vehicle infusions into the NAc subregions on the
behavioral procedures under investigation (see Figs. 1 and 2). This
difference in the baseline level of LI would be occluded by the use of
collapsed controls and hence the data are presented for the individual
vehicle-injected groups. As the aim of the current experiments was
to identify the neuroanatomical locus within the NAc of the known
effects of 6-OHDA and haloperidol on latent inhibition, the critical
comparisons at test are the effects of CS pre-exposure in each NAc
subregion following the 6-OHDA (Experiment 1) and haloperidol
(Experiment 2) treatments. Thus, in order to allow focused compar-
isons (Abelson, 1995) and in view of the unequal cell sizes the
behavioral results are analyzed separately by treatment for each
Experiment. For each treatment, (6-OHDA or vehicle in Experiment 1,
haloperidol or saline in Experiment 2), there are 4 experimental
groups run in separate 2×2 analyses of variance (ANOVA) of matched
cell size with between subject factors: pre-exposure (PE or NPE)
and subregion (core or shell). In addition, the baseline lick data are
analyzed with day (at 5 levels) as a within subject factor. T-tests were
used for planned comparisons. In line with earlier work, the animals
underwent 2 extinction tests in Experiment 1 (Joseph et al., 2000).
Thus the repeated measures ANOVAs to check for differences across
the tests had an additional within subjects factor with 2 levels (test 1
and test 2).
3. Results
3.1. Experiment 1
3.1.1. Neurotransmitter assay
Quantiﬁcation of the lesions by HPLC revealed that 6 animals
showed no evidence of NAc DA depletion, consequently these animals
were not considered for further analysis.
Tables 1a and 1b display the levels (pmol/μg protein) of DA and
noradrenalin (NA) in the 5 brain regions from which samples were
taken as (A) absolute levels and (B) as the percentage depletion
relative to vehicle-injected levels. As is clear from the tables, infusion
of 6-OHDA into core produced a mean depletion in DA of 64% in the
target structure and 47% in the adjacent shell region compared to
vehicle-injected levels. Similarly, the shell lesion led to greater
Fig. 2.Histological assessment of cannula placements within the nucleus accumbens. Representative coronal sections from rats that received microinjections of 0.5 μg haloperidol or
saline into the NAc core and NAc shell. Outlines are reproduced from Paxinos and Watson (2005) and coordinates refer to the distance in millimetres anterior to bregma.
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seen in the adjacent core (44%). Signiﬁcantly, following both
infusions, the depletions found in the adjacent region were lower
than the depletion produced by the lesion targeted on that region.
Some changes in DA levels were also found in the DLS and PL samples
following infusion of 6-OHDA into the core. The desipramine
pretreatment did not fully protect NA in that there were effects of
the 6-OHDA core infusion on NA in various of the brain regions
sampled. However, the pattern of NA depletion did not match that of
the DA depletion.Table 1a
Levels of DA and NA (pmol/μg protein) of vehicle-injected controls, core and shell
lesioned animals in core, shell, dorsolateral striatum (DLS), prelimbic (PL) and
infralimbic (IL) cortices.
DA NA
Vehicle Core
lesion
Shell
lesion
Vehicle Core
lesion
Shell
lesion
Core sample 9.688 3.466 5.439 0.325 0.214 0.285
(±1.51) (±0.502) (±0.563) (±0.028) (±0.024) (±0.028)
Shell sample 5.294 2.945 1.933 0.717 0.464 0.605
(±0.742) (±0.501) (±0.233) (±0.091) (±0.049) (±0.058)
DLS sample 10.594 7.128 8.289 0.173 0.1393 0.1266
(±0.583) (±0.461) (±0.343) (±0.114) (±0.01) (±0.012)
PL sample 0.07 0.052 0.049 0.221 0.179 0.178
(±0.008) (±0.007) (±0.006) (±0.016) (±0.012) (±0.017)
IL sample 0.82 0.039 0.064 0.244 0.165 0.207
(±0.011) (±0.006) (±0.006) (±0.024) (±0.024) (±0.018)3.1.2. Behavioral
3.1.2.1. Pre-conditioning. All animals drank in the chambers and in
both 2×2 analyses there was a gradual increase in total licks across
the 5 days of lick training (min F(4,152)=2.93, pb0.05). This increase
over days was unaffected by subregion as there were no overall effects
of this factor (max F(1,40)=2.38, p=0.13). Similarly, in both 2×2
analyses, the latency to ﬁrst lick declined over the 5 days of pre-
training (min F(4,84)=9.3, pb0.001). This increasing readiness to
drink was unaffected by subregion in the 6-OHDA treated animals
(Fb1) but there was an effect of subregion in the vehicle-infusedTable 1b
Percentage difference in DA and NA levels of core and shell lesioned animals compared
to vehicle-injected controls in the 5 brain regions assayed. * signiﬁcant difference from
sham, † signiﬁcant difference from other lesion group, pb0.05, t-test.
DA NA
Core lesion Shell lesion Core lesion Shell lesion
Core sample −64.4%*† −43.7%*† −52.3%† −7.7%
(±5.1) (±5.8) (±10.9) (±19.2)
Shell sample −46.7%*† −68.4%*† −38.8%* −9.3%†
(±9.0) (±3.9) (±14.0) (±18.9)
DLS sample −35.5%*† −16.9%† −25.6%* −24.6%*
(±4.2) (±3.9) (±6.9) (±7.4)
PL sample −28.8% −24.5% −17.5% −20.8%
(±9.5) (±9.1) (±19.4) (±16.9)
IL sample −52.5%*† −13.6%† −31.6%* −20.4%
(±6.9) (±10.5) (±16.1) (±17.0)
Fig. 3. Mean suppression ratio (±S.E.M.) to the CS for non-pre-exposed (NPE: white
bars) and pre-exposed (PE: light grey) groups following saline or haloperidol injections
in either the core or shell subregions of the nucleus accumbens.
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slowly over the 5 days of pre-conditioning relative to the core-vehicle
group (F(1,21) 11.44, pb0.01).
3.1.2.2. Reshaping. There was no effect of any of the experimental
factors on the log (10) times (s) to complete the ﬁrst lick in the
reshape session (max F(1,38)=2.12, p=0.15). Similarly, there were
no differences between the groups in the total amount drunk during
the reshape session (max F(1,38)=1.14, p=0.29).
3.1.2.3. Extinction tests. None of the experimental groups differed in
the time to make 50 licks in the absence of the tone (A period) in
either extinction test (max F(1,38)=1.73 p=0.19). Analysis of the 2
tests revealed an effect of test in both vehicle (F(1,19)=44.25,
pb0.001) and 6-OHDA groups (F(1,38)=47.23, pb0.001) as the
overall level of conditioned suppression declined across the 2 tests
consistent with extinction to the CS. However, this factor did not
interact with either subregion or pre-exposure (max F(1,38)=3.03,
p=0.09) and hence the data are presented in Fig. 1 collapsed across
the 2 tests.
Inspection of Fig. 1 reveals that as expected with limited CS pre-
exposure there was no evidence of an effect of pre-exposure on
conditioning to the CS in the vehicle-injected groups. ANOVA yielded
no effect of subregion, pre-exposure or interaction between these
factors (max F(1,19)=1.95, p=0.18) in the vehicle-treated groups.
Similarly, there was no effect of pre-exposure on conditioning to the
CS in the 6-OHDA-core-lesioned group. However, Fig. 1 shows that the
6-OHDA-shell lesion appeared to potentiate LI as the shell PE group
showed markedly less suppression to the CS than the NPE group. This
description of the data was supported statistically by an effect of pre-
exposure (F(1,38)=5.27, pb0.05) but also critically a pre-exposure×
lesion interaction (F(1,28)=5.45, pb0.05). This interaction arose
because there was no difference between the PE and NPE animals in
the 6-OHDA-core group (tb1) but a robust LI effect in the 6-OHDA-
shell group (t(21)=2.92, pb0.01).
3.2. Experiment 2
3.2.1. Histological assessment
Histological assessment conﬁrmed that 10 animals had misplaced
cannulae (7 in haloperidol-injected groups, 3 in saline-injected
groups). The remaining placements were successfully positioned in
shell versus core NAc (Fig. 2; cf. Nelson et al., in press). The ﬁnal
sample sizes were as follows: 20 haloperidol-core; 19 haloperidol-
shell; 10 saline-core; 9 saline-shell.
3.2.2. Behavioral
3.2.2.1. Pre-conditioning. There was a gradual increase in the amount
drunk across the 5 days of pre-conditioning (min F(4,148)=2.92,
pb0.05) but there was no effect of subregion (all Fsb1). Conversely,
there was a decrease in the latency to ﬁrst lick (min F(4,68)=3.51,
pb0.05). This decrease was unaffected by subregion in the saline
group (Fb1). In the haloperidol group, the shell group had overall
higher latencies than the core group (F(1,37)=4.17, pb0.05) but by
day 5 there were no differences between the two subregions (Fb1).
3.2.2.2. Reshaping. There was no effect of any of the experimental
factors on the log (10) times (s) to complete the ﬁrst lick in the
reshape session (max F(1,15)=3.12, p=0.1). Similarly, there were no
differences between the groups in the total amount drunk during the
reshape session (all Fsb1).
3.2.2.3. Extinction test. Analysis of the A period (time to make 50 licks
in the absence of the CS) revealed no effect of pre-exposure or
subregion in either saline or haloperidol-infused animals (all Fsb1).The mean suppression ratios to the CS in the extinction test are
presented in Fig. 3. ANOVA revealed an effect of pre-exposure in
both saline- (F(1,15)=10.78, pb0.005) and haloperidol-injected
animals (F(1,35)=4.24, pb0.05) but no interaction by subregion
(max F(1,15) 2.59, p=0.13). Nevertheless, as is clear from Fig. 3 the
level of conditioning to the CS was not equivalent across the
subregions and infusion groups. Enhanced LI was demonstrated as
reduced suppression in the pre-exposed compared to the non pre-
exposed group when haloperidol was injected in shell (t(17)=2.2,
pb0.05). However, there was no evidence of LI after haloperidol
injection in core (tb1). LI was similarly non-signiﬁcant after saline
injection in the shell. Unexpectedly given the limited number of pre-
exposures, saline injection at core coordinates appeared to potentiate
LI as there was a clear difference in the level of conditioning to the CS
between the pre-exposed and non pre-exposed animals (t(8)=3.45,
pb0.05).
4. Discussion
Experiment 1 tested the effects of 6-OHDA lesions targeted at the
core and medial shell of the NAc on LI under experimental conditions
(10 pre-exposures) designed to prevent the emergence of LI in
vehicle-injected controls. Consistent with previous reports vehicle-
injected animals failed to show signiﬁcant LI under these experimen-
tal parameters (e.g., Ruob et al., 1998, Schiller and Weiner, 2005;
Nelson et al., 2010a). Similarly, there was no evidence of LI in animals
with 6-OHDA lesions targeted at the core. The level of LI is assessed in
terms of the difference in the level of suppression between the NPE
and PE animals in each drug/placement group (see e.g., Feldon et al.,
1991), and on this basis LI was clearly potentiated by infusion of 6-
OHDA into the shell. Similarly, in Experiment 2, haloperidol enhanced
LI when injected in shell but not core.
In Experiment 1, assay by HPLC revealed differential depletion by
infusion site with about 65% depletion in each of the NAc subregions
targeted. This magnitude of DA depletion is less than that earlier
reported after local injection of 6-OHDA (e.g., Cousins et al., 1993;
Salamone et al., 2001; Correa et al., 2002). However, these studies
were total NAc depletions and with more selective procedures higher
levels of DA depletion produce greater concomitant depletion in the
non-targeted subregion (Sokolowski and Salamone 1998; Nelson
et al., 2010b, in press). Moreover, 6-OHDA-induced DA depletion
in the NAc has been shown to result in differential changes in the
morphology of medium spiny neurons within the core and shell
(Meredith et al., 1995). Such regionally-speciﬁc differences in the
response to DA depletion, rather than simply gross changes in DA
levels, may contribute to behavioral dissociations of the kind observed
here.
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deplete DA in the NAc region adjacent to the intended site, this
depletion was signiﬁcantly less than found in the target structure (see
Table 1b). The recent evidence of widespread intra-accumbal
projections (van Dongen et al., 2005) may underlie the pattern of
catecholaminergic dennervation that we and others have observed
with this kind of lesion (Sokolowski and Salamone 1998; Boye et al.,
2001; Sellings and Clarke, 2003; Sellings et al., 2008; Nelson et al.,
2010b, in press). The lesions, in particular the core, did also lead to
changes in DA levels within the DLS, PL and IL cortex in line with the
known pattern of corticostriatal projections of the NAc (Berendse
et al., 1992; Groenewegen et al., 1999; Haber et al., 2000). There is
no consistent evidence that these comparison regions play any direct
role in LI (Solomon and Staton, 1982; Lacroix et al., 2000; but see
Ellenbroek et al., 1997). Pretreatment with desipramine provided a
degree of neurochemical selectivity but NA was not uniformly
protected. A role for NA in LI cannot be precluded in view of the
well-established effects of the catecholamine agonist amphetamine
on LI. However, the behaviorally-effective shell lesion produced only
minimal changes in NAc NA levels, suggesting that the behavioral
effects seen at test are meditated by DA depletion within shell NAc.
Taken in isolation, Experiment 1 cannot tell us at what stage of the
procedure effects were mediated. In line with the ﬁndings of Joseph
et al. (2000), Experiment 2 conﬁrmed that LI enhancement was
mediated at the conditioning stage of the procedure, consistent with
the switching hypothesis of LI. Although the present experiments
with few pre-exposures were not standard to test for LI abolition,
and do not routinely yield LI in naïve rats, haloperidol and 6-OHDA
in core tended to attenuate rather than enhance LI relative to the
corresponding core control groups. Indeed in Experiment 2, LI in the
saline-core group achieved signiﬁcance, whereas LI in the haloperi-
dol-core group was not signiﬁcant. This raises the possibility that
intra-core haloperidol injection was not without effect, but rather
than potentiating LI as at the shell placement, LI was reduced by
haloperidol in the core. However, the unexpected difference in the
saline-injected control groups means that this possibility cannot be
distinguished from the effect on LI of the saline injection. Thus the
effects of haloperidol injection in core should be further examined
using non-injected groups to control for any mechanical damage
produced by the saline infusion, which based on electrolytic and
excitotoxic lesion studies would be expected to enhance LI (Weiner,
2003; Gal et al., 2005; Schiller et al., 2006). Notwithstanding this issue,
the present data can be interpreted as showing, that under the speciﬁc
conditions of this study, that DA depletion and blockade in the core do
not potentiate LI.
Together the results of Experiments 1 and 2 underscore the
dissociable roles of core and shell subregions of the NAc in mediating
the expression of LI and suggest that speciﬁcally reduced activity at
DA D2-like receptors within the medial shell leads to enhanced LI.
This conclusion is supported by in vivo studies of DA release in NAc
showing that the expression of LI is associated with reduced DA
release within the medial shell but not core NAc. Speciﬁcally, it has
been demonstrated that extracellular levels of DA are increased in the
medial shell when a CS is paired with an aversive event but that this
conditioned release is eliminated following non-reinforced pre-
exposure to the CS (Murphy et al., 2001; Jeanblanc et al., 2002; 2003).
In terms of the switching hypothesis of LI, increased DA efﬂux
in the shell at the time of conditioning may serve to release the
switching mechanism, posited to reside in the core, from shell-
mediated inhibition and allow the organism to respond adaptively to
the CS-reinforcement contingency (Weiner, 2003). As stimulus pre-
exposure abolishes this phasic DA response, the core switching
mechanism is not activated and hence behavior is controlled by the
CS-no event contingency acquired at pre-exposure. In Experiment 1,
the 6-OHDA-induced depletion of shell DA could mimic the effects of
non-reinforced pre-exposure by further attenuating this conditionedDA release and thus lead to the emergence of LI even under conditions
(limited pre-exposure) that do not produce LI in controls. A similar
mechanism could underlie the potentiation of LI produced in
Experiment 2, where DA D2 receptors were selectively antagonized
by haloperidol injection in shell. Within this framework, reduced DA
function in the core would not be expected to affect LI as phasic DA
release in shell would still activate the core-mediated switching
mechanism. This is exactly the pattern of results we observed here
with 6-OHDA lesions to, or haloperidol injection in, core NAc. Seen in a
broader context of accumbal function, this proposition is consistent
with data indicating that the shell modulates the attribution of
motivational valence to stimuli, while the core mediates behavioral
output to conditioned stimuli (Meredith et al., 2008). Seen in the
context of the LI model of schizophrenia, the results of Experiment 2
are consistent with other evidence that NAc shell is the neural locus of
action of antipsychotic drugs (Deutch et al., 1992; Dilts et al., 1993).Acknowledgements
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